PL4401743T3 - Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii - Google Patents

Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii

Info

Publication number
PL4401743T3
PL4401743T3 PL22789675.0T PL22789675T PL4401743T3 PL 4401743 T3 PL4401743 T3 PL 4401743T3 PL 22789675 T PL22789675 T PL 22789675T PL 4401743 T3 PL4401743 T3 PL 4401743T3
Authority
PL
Poland
Prior art keywords
orthopedics
amino acids
field
composition containing
sodium hyaluronate
Prior art date
Application number
PL22789675.0T
Other languages
English (en)
Inventor
Edoardo CONTI
Original Assignee
Professional Derma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Derma Sa filed Critical Professional Derma Sa
Publication of PL4401743T3 publication Critical patent/PL4401743T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PL22789675.0T 2021-09-16 2022-09-15 Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii PL4401743T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102021000023894A IT202100023894A1 (it) 2021-09-16 2021-09-16 Composizione per utilizzo in campo ortopedico
PCT/IB2022/058720 WO2023042120A1 (en) 2021-09-16 2022-09-15 Composition comprising sodium hyaluronate and am inoacids for use in the orthopedic filed

Publications (1)

Publication Number Publication Date
PL4401743T3 true PL4401743T3 (pl) 2025-12-15

Family

ID=78771031

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22789675.0T PL4401743T3 (pl) 2021-09-16 2022-09-15 Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii

Country Status (11)

Country Link
US (1) US20240366653A1 (pl)
EP (1) EP4401743B1 (pl)
KR (1) KR20240063914A (pl)
CN (1) CN117957004A (pl)
AU (1) AU2022345524A1 (pl)
ES (1) ES3052874T3 (pl)
HR (1) HRP20251328T1 (pl)
IT (1) IT202100023894A1 (pl)
PL (1) PL4401743T3 (pl)
RS (1) RS67349B1 (pl)
WO (1) WO2023042120A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU505892B1 (fr) * 2023-12-21 2025-06-24 Lumatrix Formule pharmaceutique de cicatrisation et de régénération de la peau et son utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052515A1 (it) * 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
CA2910325A1 (en) * 2013-04-25 2014-10-30 Aluron Biopharma Inc. Crosslinked hyaluronic acid compositions

Also Published As

Publication number Publication date
AU2022345524A1 (en) 2024-02-15
HRP20251328T1 (hr) 2025-12-19
IT202100023894A1 (it) 2023-03-16
EP4401743B1 (en) 2025-09-03
CN117957004A (zh) 2024-04-30
RS67349B1 (sr) 2025-11-28
EP4401743C0 (en) 2025-09-03
ES3052874T3 (en) 2026-01-15
WO2023042120A1 (en) 2023-03-23
KR20240063914A (ko) 2024-05-10
US20240366653A1 (en) 2024-11-07
EP4401743A1 (en) 2024-07-24

Similar Documents

Publication Publication Date Title
MX376139B (es) Formulaciones y metodos de tratamiento con queratina.
EP4212524A4 (en) Cd73 inhibitor and application thereof in medicine
ITRM20030210A1 (it) Protesi da impiegarsi nella terapia chirurgica del prolasso
BR112015007746A2 (pt) formulação aquosa estéril injetável, kit contendo a formulação aquosa estéril injetável e processo de fabricação de uma formulação aquosa estéril injetável
ZA202007834B (en) Compositions comprising amino acids for use in the prevention and treatment of liver diseases
NO20051539L (no) N-biarylmetylaminosykloalkankarboksamidderivater
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
BR112015026247A8 (pt) composto em combinação com um análogo de citidina, composição farmacêutica que os compreende, uso dos mesmos e kit
IL308041A (en) Collagen compositions and methods of using them
MA48464A (fr) Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques
PL4132895T3 (pl) Kompozycja częściowo protonowanych alkanoloamin i zastosowanie w młynie
ZA202207728B (en) Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
PL4401743T3 (pl) Kompozycja zawierająca hialuronian sodu i aminokwasy do stosowania w dziedzinie ortopedii
PH12019501999A1 (en) Pyrazole derivatives as bromodomain inhibitors
PL3478310T3 (pl) Kompozycje przydatne w zapobieganiu i/lub leczeniu zapalenia i bólu stawów i kości oraz uszkodzenia chrząstki
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
IL290846A (en) Liquid compositions comprising a levodopa amino acid conjugate and uses thereof
EP4262637C0 (en) IMPROVEMENTS MADE IN OR RELATING TO SURGICAL METHODS AND SYSTEMS
DE60307665D1 (de) Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure
BR112018003455A2 (pt) composição ou composição farmacêutica e uso da composição
MX2022007219A (es) Compuestos y su uso para el tratamiento contra la deficiencia de ¿1- antitripsina.
EP3819362A4 (en) GEL-SHAPED DETERGENT COMPOSITION AND DETERGENT PRODUCT
PL3813882T3 (pl) Kombinacja farmaceutyczna zawierająca biguanid i inhibitor acetylocholinoesterazy do stosowania w chorobach związanych z wiekiem i/lub chorobach zwyrodnieniowych
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat